<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autologous hematopoietic stem cell transplantation (HSCT) is currently being evaluated as a treatment for <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, including <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), that are associated with a very severe prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a 27-year-old woman with SLE with a 10-year history of refractory <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>She developed progressive <z:hpo ids='HP_0001700'>myocardial necrosis</z:hpo> despite treatment with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (CYC), <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>, and immunopheresis </plain></SENT>
<SENT sid="3" pm="."><plain>After conditioning with CYC, fludarabine, and antithymocyte globulin, autologous HSCT using CD34(+) selection was performed </plain></SENT>
<SENT sid="4" pm="."><plain>After transplantation, the clinical symptoms caused by APS remitted, and the serum anticardiolipin antibody level decreased </plain></SENT>
<SENT sid="5" pm="."><plain>Remission has persisted for 21 months after transplantation </plain></SENT>
<SENT sid="6" pm="."><plain>Although a longer follow-up is required for the assessment of efficacy, autologous HSCT may cure patients with refractory APS </plain></SENT>
</text></document>